In patients receiving risperidone monotherapy, plasma concentrations in patients with the wild-type genotype showed a decreasing and then increasing pattern, whereas those patients with the mutant homozygous showed an increasing trend from week 3 to week 12.
← all excerpts
Association of <i>HTR1A</i> Gene Polymorphisms with Efficacy and Plasma Concentrations of Atypical Antipsychotics in the Treatment of Male Patients with Schizophrenia.
1
—
—